Stepwise differentiation of follicular helper T cells reveals distinct developmental and functional states.
Journal
Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555
Informations de publication
Date de publication:
24 Nov 2023
24 Nov 2023
Historique:
received:
05
04
2023
accepted:
08
11
2023
medline:
27
11
2023
pubmed:
25
11
2023
entrez:
24
11
2023
Statut:
epublish
Résumé
Follicular helper T (Tfh) cells are essential for the formation of high affinity antibodies after vaccination or infection. Although the signals responsible for initiating Tfh differentiation from naïve T cells have been studied, the signals controlling sequential developmental stages culminating in optimal effector function are not well understood. Here we use fate mapping strategies for the cytokine IL-21 to uncover sequential developmental stages of Tfh differentiation including a progenitor-like stage, a fully developed effector stage and a post-effector Tfh stage that maintains transcriptional and epigenetic features without IL-21 production. We find that progression through these stages are controlled intrinsically by the transcription factor FoxP1 and extrinsically by follicular regulatory T cells. Through selective deletion of Tfh stages, we show that these cells control antibody dynamics during distinct stages of the germinal center reaction in response to a SARS-CoV-2 vaccine. Together, these studies demonstrate the sequential phases of Tfh development and how they promote humoral immunity.
Identifiants
pubmed: 38001088
doi: 10.1038/s41467-023-43427-4
pii: 10.1038/s41467-023-43427-4
pmc: PMC10674016
doi:
Substances chimiques
COVID-19 Vaccines
0
Transcription Factors
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
7712Subventions
Organisme : NIAID NIH HHS
ID : P01 AI056299
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI153124
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI158413
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI158175
Pays : United States
Informations de copyright
© 2023. The Author(s).
Références
Methods Mol Biol. 2022;2380:175-185
pubmed: 34802131
Immunity. 2022 Feb 8;55(2):272-289.e7
pubmed: 35081372
Nat Immunol. 2019 Mar;20(3):326-336
pubmed: 30778252
Annu Rev Immunol. 2016 May 20;34:335-68
pubmed: 26907215
Curr Opin Immunol. 2020 Dec;67:68-74
pubmed: 33176227
Immunol Rev. 2020 Jul;296(1):104-119
pubmed: 32564426
Cell Rep. 2020 Oct 6;33(1):108232
pubmed: 33027650
FASEB J. 2016 Feb;30(2):761-74
pubmed: 26499265
Nat Immunol. 2019 Oct;20(10):1360-1371
pubmed: 31477921
Nature. 2006 May 11;441(7090):235-8
pubmed: 16648838
J Exp Med. 2010 Feb 15;207(2):365-78
pubmed: 20142430
Nat Commun. 2022 Feb 10;13(1):805
pubmed: 35145086
Nat Immunol. 2019 Feb;20(2):163-172
pubmed: 30643263
Blood. 2009 May 28;113(22):5536-48
pubmed: 19307668
Nature. 2018 Aug;560(7719):494-498
pubmed: 30089906
Cell Rep. 2017 Oct 3;21(1):208-221
pubmed: 28978474
J Clin Invest. 2014 Dec;124(12):5191-204
pubmed: 25347469
J Virol. 2013 Jul;87(13):7737-46
pubmed: 23637417
Nat Immunol. 2015 Sep;16(9):980-90
pubmed: 26214741
Nat Immunol. 2019 Feb;20(2):232-242
pubmed: 30643266
Nat Immunol. 2016 Dec;17(12):1436-1446
pubmed: 27695002
Nat Immunol. 2021 Aug;22(8):1020-1029
pubmed: 34312547
Immunity. 2022 Jan 11;55(1):115-128.e9
pubmed: 35021053
Trends Immunol. 2021 Apr;42(4):336-349
pubmed: 33663954
Nat Immunol. 2012 May;13(5):491-8
pubmed: 22466669
Nat Immunol. 2016 Oct;17(10):1197-1205
pubmed: 27573866
Cell Rep. 2016 Feb 23;14(7):1735-1747
pubmed: 26876184
Nature. 2021 Jul;595(7869):724-729
pubmed: 34234346
Immunity. 2022 Aug 9;55(8):1414-1430.e5
pubmed: 35896116
J Exp Med. 2022 Jan 3;219(1):
pubmed: 34792530
Proc Natl Acad Sci U S A. 2014 Aug 12;111(32):11792-7
pubmed: 25071203
Cell. 2021 Dec 22;184(26):6281-6298.e23
pubmed: 34875227
F1000Res. 2020 Jan 27;9:47
pubmed: 32789006
Cell Rep. 2022 Feb 22;38(8):110399
pubmed: 35139367
Nat Immunol. 2014 Jul;15(7):667-75
pubmed: 24859450
Am J Transplant. 2021 May;21(5):1893-1901
pubmed: 33421294
Science. 2021 Jul 16;373(6552):
pubmed: 34437125
J Immunol. 2019 Apr 15;202(8):2229-2239
pubmed: 30833348
J Exp Med. 2010 Feb 15;207(2):353-63
pubmed: 20142429
Nat Biotechnol. 2014 Apr;32(4):381-386
pubmed: 24658644
J Exp Med. 2019 Mar 4;216(3):605-620
pubmed: 30705058
Sci Immunol. 2021 May 28;6(59):
pubmed: 34049865
Nature. 2016 Sep 15;537(7620):417-421
pubmed: 27501248
Genome Biol. 2018 Dec 19;19(1):224
pubmed: 30567574
Immunity. 2019 May 21;50(5):1132-1148
pubmed: 31117010
Immunity. 2008 Jul 18;29(1):127-37
pubmed: 18602282